A 68-year-old man with a 50 pack-year smoking history presents with progressive dyspnea, chronic productive cough, and barrel chest. Spirometry shows post-bronchodilator FEV1 of 22% predicted and FEV1/FVC ratio of 0.58. His arterial blood gas on room air reveals PaO2 52 mmHg, PaCO2 48 mmHg, and pH 7.38. The spirometric findings shown in the diagram correspond to the structure marked **A**. Which of the following is the most appropriate immediate management for this patient's respiratory status?

Explanation

## Why option 1 is correct The patient's spirometry (FEV1 <30% predicted, FEV1/FVC <0.70) defines GOLD 4 very severe COPD, as marked by structure **A** in the diagram. His resting PaO2 of 52 mmHg (≤55 mmHg) on room air meets the primary indication for long-term oxygen therapy (LTOT) per NOTT and MRC trials. LTOT ≥15 hours daily is the only pharmacological intervention (besides smoking cessation and lung transplant) with proven mortality benefit in advanced COPD. The target SpO2 of 88–92% avoids CO2 retention and respiratory acidosis. His current PaCO2 (48 mmHg) and pH (7.38) indicate stable chronic hypercapnia, not acute respiratory failure requiring immediate NIV. ## Why each distractor is wrong - **Option 2 (short-acting bronchodilators + lung transplant)**: While short-acting bronchodilators are part of GOLD 4 management, lung transplant is reserved for BODE index 7–10 and is not the "immediate" management for hypoxemia. LTOT must be initiated first in stable disease. - **Option 3 (BiPAP for chronic hypercapnic respiratory failure)**: BiPAP is indicated for acute respiratory acidosis (pH <7.35 + PaCO2 >45) during exacerbation or for chronic hypercapnic failure refractory to LTOT. This patient has stable chronic hypercapnia (pH 7.38) without acute decompensation; LTOT is the appropriate first step. - **Option 4 (corticosteroids + antibiotics)**: These are reserved for acute exacerbations (increased sputum purulence/volume, acute dyspnea, or respiratory acidosis). The patient's stable ABG and absence of exacerbation signs make this inappropriate. **High-Yield:** GOLD 4 COPD with PaO2 ≤55 mmHg at rest = LTOT indication; NOTT/MRC trials proved mortality benefit; target SpO2 88–92% to avoid CO2 retention. [cite: GOLD 2024 Global Strategy for Prevention, Diagnosis and Management of COPD; Harrison's Principles of Internal Medicine, 21st ed., Ch. 286; NOTT/MRC trials]